Dockets Home | Accessibility | Dockets Contacts and Location | Operating Status | Item Codes

DOCKETS ENTERED on 1/28/03

Docket Number - Title

97S-0162 30-Day Structure Function Claim Notification Letters Dietary

LET 9591 Twin Laboratories Inc Vol#: 73

LET 9592 Twin Laboratories Inc Vol#: 73

LET 9593 Aboca USA Inc Vol#: 73

LET 9594 Aboca USA Inc Vol#: 73

LET 9595 Aboca USA Inc Vol#: 73

LET 9596 Inverness Medical, Inc. Vol#: 73

LET 9597 Source Naturals, Inc Vol#: 73

LET 9598 Fuji Travel Center, Inc. Vol#: 73

LET 9599 Herbalife International of America Inc Vol#: 73

LET 9600 Twin Laboratories Inc Vol#: 73

99N-4282 Biotechnology in the Year 2000 and Beyond; Public Meetings

EMC 3871 number not used Vol#: 513

EMC 3872 number not used Vol#: 513

EMC 3873 number not used Vol#: 513

EMC 3874 number not used Vol#: 513

EMC 3875 number not used Vol#: 513

EMC 3876 number not used Vol#: 513

EMC 3877 number not used Vol#: 513

EMC 3878 number not used Vol#: 513

EMC 3879 number not used Vol#: 513

EMC 3880 number not used Vol#: 513

EMC 3881 number not used Vol#: 513

EMC 3882 number not used Vol#: 513

EMC 3883 Carolyn Waller Vol#: 513

EMC 3884 Lisa LaBudde Vol#: 513

EMC 3885 Cynthia Woodford Vol#: 513

EMC 3886 William Powers Vol#: 513

EMC 3887 Louis Fox Vol#: 513

EMC 3888 F. G. Sholz Vol#: 513

EMC 3889 Rosemary Fox Vol#: 513

EMC 3890 number not used Vol#: 513

EMC 3891 Lara Pizzorno Vol#: 513

EMC 3892 Scott Buesing Vol#: 513

EMC 3893 Joan Espana Vol#: 513

EMC 3894 Chris Krumm Vol#: 513

EMC 3895 Carol Winkelman Vol#: 513

EMC 3896 Tanya Rampersad Vol#: 513

00D-1598 Voluntary Labeling for Bioengineered Foods

EMC 11883 Form Letter Count Vol#: 573

00N-1367 Postmarket Surveillance

NAL 1 Vol#: 1

SS 1 Supporting Statement Vol#: 1

00N-1529 Proposal to Debar Elaine Yee-Ling Lai:Notice of Opportunity

NCR 1 Vol#: 1

00N-1571 Enrofloxacin for Poultry: Opportunity for Hearing

CS 26 HFA-305 Vol#: 359

OR 28 HF-3 Vol#: 359

01N-0393 Prescription Drug Product Labeling; Medication Guide Require

NAL 1 Vol#: 1

SS 1 Supporting Statement Vol#: 1

01N-0400 Safety & Effectiveness of New Drug & Biological Products in

NAL 1 Vol#: 1

SS 1 Supporting Statement Vol#: 1

02N-0268 Cosmetic Product Voluntary Reporting Program;Information Col

NAL 1 Vol#: 1

SS 1 Supporting Statement Vol#: 1

02N-0418 Adverse Experience Reporting for Licensed Biological Produts

N 2 Vol#: 1

03N-0009 Federal Preemption of State & Local Medical Device Requireme

N 1 Vol#: 1

03P-0027 Amend labeling for skelaxin (metaxalone) tablets to restore

ACK 1 HFA-305 Vol#: 1

CP 1 Eoc Labs, Inc. Vol#: 1

03V-0026 Laser Light Show

ACK 1 HFA-305 Vol#: 1

VAR 1 Long Beach Transit Vol#: 1